Overall rank by patents
#12,350
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Alpine Immune Sciences, Inc.
USPTO PatentsView assignee record - 24 granted patents across 7 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07K (PEPTIDES).
24
Total patents granted
7
CPC technology areas
24.1
Avg claims per patent
-
5-year filing velocity
The verdict
Alpine holds 24 US patents across 7 technology areas, rank #12,350 of 50,000 tracked assignees.
- #12,350
- of 50,000 US assignees by volume
- Top 13%
- by Innovation Score (50.5/100)
- 24.1
- avg claims per patent
Portfolio overview
Alpine Immune Sciences, Inc. has been granted 24 US utility patents between 2021 and 2025, placing Alpine Immune Sciences, Inc. at rank #12,350 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.1 claims per patent with primary concentration in C07K (PEPTIDES). As a US Corporation, Alpine Immune Sciences, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 50.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 24 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Alpine Immune Sciences, Inc.'s 24.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Alpine Immune Sciences, Inc. against peers pursuing similar technology classes.
How does Alpine compare?
Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Alpine Immune Sci… ◀ 24
Alpine Immune Sciences, Inc.
24 patents
What this shows Alpine holds 24 patents, placing it at rank #12,350 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Alpine's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
50 Top 13% higher than 87% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2021–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 6 | 25.0% |
| 2022 | 7 | 29.2% |
| 2023 | 5 | 20.8% |
| 2024 | 2 | 8.3% |
| 2025 | 4 | 16.7% |
Which technologies does Alpine Immune Sciences, Inc. patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Frequently Asked Questions
How many patents does Alpine Immune Sciences, Inc. hold?
Alpine Immune Sciences, Inc. holds 24 US granted patents filed between 2021 and 2025, spanning 7 technology areas.
What is Alpine Immune Sciences, Inc.'s Innovation Score?
Alpine Immune Sciences, Inc. has an Innovation Score of 50.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Alpine Immune Sciences, Inc. focus on?
Alpine Immune Sciences, Inc.'s top technology area is C07K (PEPTIDES) with 24 patents. The company has filed patents in 7 CPC subclasses total.
Is Alpine Immune Sciences, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Alpine Immune Sciences, Inc..
What does claim depth mean for Alpine Immune Sciences, Inc.'s patents?
Alpine Immune Sciences, Inc.'s patents average 24.1 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Alpine Immune Sciences, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Guides to patent portfolio analysis
How to use this portfolio
Alpine's 24 grants land it in the top 13% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Alpine ranks #12,350 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C07K - see who else leads that technology area. C07K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Explore the patent dataset
C07K technology
Alpine Immune Sciences, Inc.'s primary CPC class, all holders and yearly trends
Top 50 patent holders
See where Alpine Immune Sciences, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Data sources used on this page
- USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
- Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
- USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov
